Amman: Jordan Food and Drug Administration (JFDA) underlined the importance of administering intravenous iron infusions under medical supervision to ensure "correct" dosage and prevent potential health complications, primarily allergic reactions that may require emergency procedures due to the rare but serious risk to life. In a statement issued Sunday, the JFDA detailed that allergic reactions can surface as mild symptoms, mainly skin rash, itching, redness, a feeling of warmth or tingling, slight swelling in the face or hands, shortness of breath or wheezing, while the acute symptoms can involve anaphylactic shock, mainly severe difficulty in breathing, rapid or irregular heartbeat, and significant drops in blood pressure. The JFDA advised people, who suffered these symptoms after receiving an iron infusion, should immediately seek medical attention at the nearest hospital or emergency center. Source: Jordan News Agency
Related Articles
Bin Habtoor commends role of private sector’s investment in higher education
Caretake Prime Minsiter Dr. Abdulaziz Saleh bin Habtoor, praised the Private Sector’s vital role in investment and its positive contribution in the field of higher education.
This came during a meeting with the Prime Minister on Saturday with his Dep…
Government media in Gaza: One million cases of infectious diseases as a result of displacement
Gaza – Together – The government media office in the Gaza Strip announced, on Monday, that there are more than one million cases of infectious diseases as a result of displacement in the Gaza Strip, which has been exposed to a devastating Israeli war …
JSO records 4.7-magnitude earthquake south of Saudi Jeddah city
Amman: The Jordanian Seismological Observatory (JSO) recorded an earthquake south of the Saudi city of Jeddah in the Red Sea measuring 4.7 on the Richter scale at Saturday dawn at 00:09 Amman time.
In a statement, the observatory indicated that the t…
